Praxis Impact Large Cap Value ETF (NYSEARCA:PRXV) Short Interest Down 72.9% in August

Praxis Impact Large Cap Value ETF (NYSEARCA:PRXV) was the target of a large drop in short interest during the month of August. As of August 14th, there was short interest totaling 2,937 shares, a drop of 72.9% from the July 30th total of 10,852 shares. Based on an average daily trading volume, of 15,716 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.1% of the company’s stock are short sold.

Institutional Trading of Praxis Impact Large Cap Value ETF

A hedge fund recently raised its position in Praxis Impact Large Cap Value ETF stock. EverSource Wealth Advisors LLC increased its holdings in shares of Praxis Impact Large Cap Value ETF (NYSEARCA:PRXV) by 11.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,375,888 shares of the company’s stock after purchasing an additional 139,733 shares during the quarter. Praxis Impact Large Cap Value ETF makes up about 1.5% of EverSource Wealth Advisors LLC’s investment portfolio, making the stock its 9th biggest holding. EverSource Wealth Advisors LLC owned 67.12% of Praxis Impact Large Cap Value ETF worth $41,720,000 at the end of the most recent quarter.

Praxis Impact Large Cap Value ETF Stock Performance

NYSEARCA PRXV traded down $0.01 during trading on Friday, hitting $36.19. The stock had a trading volume of 6,655 shares, compared to its average volume of 7,735. The company has a market capitalization of $78.53 million, a PE ratio of 18.61 and a beta of 0.43. The company’s 50-day moving average price is $35.55 and its two-hundred day moving average price is $33.62. Praxis Impact Large Cap Value ETF has a 12 month low of $28.95 and a 12 month high of $36.65.

About Praxis Impact Large Cap Value ETF

The Praxis Impact Large Cap Value ETF (PRXV) is an exchange-traded fund that is based on the CRSP US Large Cap Value index. The Praxis Impact Large Cap Value ETF seeks capital appreciation. PRXV was launched on Apr 8, 2025 and is issued by Praxis.